The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
about
A Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesThe quasi-parallel lives of satellite cells and atrophying musclePharmacology of manipulating lean body massThe molecular basis for load-induced skeletal muscle hypertrophyAbnormal Activation of BMP Signaling Causes Myopathy in Fbn2 Null MiceMechanosensitive Molecular Networks Involved in Transducing Resistance Exercise-Signals into Muscle Protein AccretionSkeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling.Intramuscular adipogenesis is inhibited by myo-endothelial progenitors with functioning Bmpr1a signalling.Extracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration.Bone Morphogenetic Protein (BMP) signaling in development and human diseasesSupraphysiological levels of GDF11 induce striated muscle atrophySmads as muscle biomarkers in amyotrophic lateral sclerosisSwimming-induced exercise promotes hypertrophy and vascularization of fast skeletal muscle fibres and activation of myogenic and angiogenic transcriptional programs in adult zebrafish.Loss of BMPR2 leads to high bone mass due to increased osteoblast activityTransforming Growth Factor Beta (TGF-β) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression.Bone morphogenetic protein signaling in rotator cuff muscle atrophy and fatty infiltration.Transcriptional Pathways Associated with Skeletal Muscle Changes after Spinal Cord Injury and Treadmill Locomotor Training.Role of IGF-I in follistatin-induced skeletal muscle hypertrophy.Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass.Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy.mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regenerationNew function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.MuSK is a BMP co-receptor that shapes BMP responses and calcium signaling in muscle cells.Bone Morphogenetic Proteins and myostatin pathways: key mediator of human sarcopenia.New roles for Smad signaling and phosphatidic acid in the regulation of skeletal muscle mass.Defining the Balance between Regeneration and Pathological Ossification in Skeletal Muscle Following Traumatic Injury.Bone morphogenetic protein signaling in vertebrate motor neurons and neuromuscular communication.The Role of TGFβ in Bone-Muscle Crosstalk.Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.IRS4, a novel modulator of BMP/Smad and Akt signalling during early muscle differentiation.Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in locomotor and respiratory muscles during experimental sepsis in mice.Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.Follistatin is critical for mouse uterine receptivity and decidualization.Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARγ and GLUT4 upregulation.Gonad-related factors promote muscle performance gain during postnatal development in male and female mice.lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy.Identification of genome-wide selection signatures in the Limousin beef cattle breed.Myostatin propeptide mutation of the hypermuscular Compact mice decreases the formation of myostatin and improves insulin sensitivity.
P2860
Q26739015-B37FD2F1-07C2-4A39-A359-723429451FAEQ26800207-7C85BC59-721B-4117-9094-8B77494A4D6CQ26824503-DBA97527-D01F-4154-8B84-D70DFB85EC25Q26829477-42668E0B-C58B-4FFC-9123-C32166CC92CDQ27310854-973211D1-CEBA-4890-AE23-62F5948BFED1Q28079049-4EDFF8C3-1050-43A6-A3C5-C3A0C25511AAQ33602302-CB698DA1-7DE6-489C-BBDA-5A5099AB7EA7Q33855785-C18ACA26-F02F-4DA4-AFE1-0834C4D8F8D4Q33980534-5F28A504-09B3-447E-9888-E51E5EE7AD52Q34512444-24856676-0393-48F7-87D7-DF89A83B8E62Q34552864-46B93CA5-1C0C-486D-A065-B86C52F57FC2Q34562847-2BDC0606-8C52-4411-8798-00B9ADB30FE0Q35228265-9376EFCE-816C-4992-8824-82F420DDFA07Q35233209-CF5E076C-7C7F-4C3B-B4F9-5DC00C56C4C3Q35777281-7A96D000-ABF2-4CB1-AA85-C5F0D02383EFQ35831815-EDFF2DE7-7A79-4B52-AAFF-7B2B1881D342Q36031922-2EE75739-1E7D-4519-9F09-639FF4A2D51EQ36066585-69450BF9-85BD-4C0B-949F-38F73DCCCE82Q36890245-1ECA2E46-2DA3-4BD4-8BA2-D7511A6500FEQ37066013-8F07858E-E3D2-4325-B033-3204ABAE06ECQ37469156-6EC371EC-089A-4C02-B381-ACA7834C5ADDQ37510390-B6413E87-9FFB-4646-A55B-797F6C3EFEC2Q37592108-9221BE54-A90B-41F4-B11E-C909BAB42AA4Q37643005-0002A7C5-15DA-40F1-899A-56CA94D45616Q37682599-CF090AC1-AB9A-409E-A1A2-6434A8D65F59Q37733728-583ABEEC-181F-4D7E-B8D7-DA8D962CBEF5Q38352456-74AD6D7A-925F-478C-9167-386038A52AC4Q39120074-4B45C07D-CD2C-40E1-96C7-55A78BE0ECE1Q40162611-FBCBC5D9-DD4D-4A27-8480-44DB379BEB08Q41458783-AF8E39EE-DEF3-4C36-B441-17C84CA81225Q41538929-45126057-5F2D-46F5-927B-BCE01A6B54CDQ41550650-B218ADC5-95DB-480F-AB2C-DA88FC8FB92BQ42471372-B80ACC51-54C1-4A25-8308-084F54A60487Q46566010-3BFED213-9E29-4423-A5A0-F6BDEB5E6F28Q47100877-5AEC847B-675B-44CD-A4D0-273C80C54591Q47141298-E5E3C88A-EFF4-494B-8098-A28902C88299Q47812619-C815E21F-44B5-4911-ABFA-21860791CECDQ47881619-E0E41466-9E5E-4A84-99AA-4CB9FF3698E8Q48712964-1C5A09FE-3B16-4510-9110-3041018A7F1DQ51269030-FA74BBAB-CADA-4A51-A5D3-048157423B32
P2860
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@en
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@nl
type
label
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@en
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@nl
prefLabel
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@en
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
@nl
P2093
P2860
P50
P356
P1476
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
@en
P2093
Catherine E Winbanks
Claudia Beyer
Julie R McMullen
Justin L Chen
Rachel E Thomson
Timothy Connor
Yingying Liu
P2860
P304
P356
10.1083/JCB.201211134
P407
P50
P577
2013-10-21T00:00:00Z